Characterization of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as Novel Leads to Development of Mu Opioid Receptor Selective Antagonists-Reference-Cited by-同舟云学术

Characterization of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as Novel Leads to Development of Mu Opioid Receptor Selective Antagonists

Published:2011-05-11 Issue:7 Volume:2 Page:346-351
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Yuan Yunyun¹,Li Guo¹,He Hengjun²,Stevens David L.²,Kozak Patrick²,Scoggins Krista L.²,Mitra Pallabi³,Gerk Phillip M.³,Selley Dana E.²,Dewey William L.²,Zhang Yan¹

Affiliation:

1. Department of Medicinal Chemistry, Virginia Commonwealth University, 800 East Leigh Street, Richmond, Virginia 23298, United States

2. Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States

3. Department of Pharmaceutics, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/cn2000348

Reference24 articles.

1. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents